Discussing edaravone with the ALS patient: an ethical framework from a U.S. perspective
Sign Up to like & getrecommendations! Published in 2018 at "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"
DOI: 10.1080/21678421.2018.1425455
Abstract: Abstract The recent approval of edaravone by the United States Food and Drug Administration has generated a mix of hope tempered by reality. The costs of the drug, both monetarily and with regard to intensity… read more here.
Keywords: ethical framework; patient ethical; discussing edaravone; als patient ... See more keywords